Author: Frontier Biotechnologies
/
2023-07-22 20:10
/
Source: Frontier Biotechnologies
/DISREGARD RELEASE: Frontier Biotechnologies/
We are advised by Frontier Biotechnologies that journalists and other readers in Malaysia should disregard the news release,"Frontier Biotechnologies' Long-acting Injectable (Aikening(R)),In A Two Drug Regimen,Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients",issuedon Oct. 27,2021 by Frontier Biotechnologiesover PR Newswire.
Tags: Biotechnology Health Care/Hospital
Previous:Launch of #SGUnited COVID-19 Assistance Telemedicine Initiative by UNO Tech
Next:World Stroke Day: Global survey reveals only 35% hospitals worldwide provide ess...
Leave a comment
Follow Us
Newsletter
Join us to get the latest news.
